“We often think about big data as this big, cold, robotic thing; and I think it reveals, in real time to us daily, that there are opportunities for many small, important moments and many impactful, emotional things to happen for patients and caregivers.” —Amy Hutnik, General Manager, Agency, Advisory & Evidence Services When the life […]
Innovative Therapies Deserve Innovative Strategies
With more than 7,000 distinct types of rare and genetic diseases and 400+ million individuals suffering from a rare disease, regenerative medicine holds the hope for a cure – transforming healthcare by revolutionizing patient care from conventional treatment models to curative therapy models. With the advancement of new technologies coupled with the creation of new companies offering a range of innovative products and treatments, regenerative medicine constitutes one of the fastest-growing fields of research and the promise of commercial success for all patients.
Creating better patient experiences and bringing effective therapies to patients around the world
In the value-driven healthcare environment, rare and orphan drug manufacturers are becoming increasingly aware that new models and new approaches are needed for a successful product launch. At EVERSANA, we understand the complexities of developing products for small populations that require global reach. That’s why we are focused on an end-to-end process that’s connected and assures that patients are identified, diagnosed and onboarded and that they stay adherent to their therapies.